- Home
- ADIL vs ACCS Comparison
ADIL vs ACCS Comparison
Compare ADIL & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADIL | ACCS |
|---|---|---|
| Founded | 2010 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Publishing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.5M | 19.1M |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ADIL | ACCS |
|---|---|---|
| Price | $4.20 | $4.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $37.50 | $14.00 |
| AVG Volume (30 Days) | ★ 51.3K | 29.1K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 139.36 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $22,619,000.00 |
| Revenue This Year | N/A | $7.40 |
| Revenue Next Year | N/A | $8.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $4.74 |
| 52 Week High | $7.20 | $11.35 |
Technical Indicators
Market Signals| Indicator | ADIL | ACCS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.61 |
| Support Level | N/A | $4.74 |
| Resistance Level | N/A | $5.83 |
| Average True Range (ATR) | 0.00 | 0.26 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.00 | 32.64 |
Price Performance
Historical ComparisonAbout ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.